Current News Releases
Combining two checkpoint inhibitors, drugs that remove inhibitory signals and restore the immune system’s ability to fight cancer, may be effective in shrinking melanoma tumors or preventing their growth in some patients who previously received standard therapy, according to new research results from the Johns Hopkins Bloomberg~Kimmel Institute. (ASCO Abstract 9520).
What: The Annual Conference on Retroviruses and Opportunistic Infections
When: Feb. 13–16, 2017
Where: Seattle, Washington, Washington State Convention Center
(705 Pike St., Seattle, WA 98101)